Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HBM

Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value

Here are three low-priced stocks you can buy today that are positioned in sector that make them solid choices to double in 2025

MarketBeat

Singapore slots itself into AI supply chain with a $7 billion investment from Micron

It’s Singapore’s first facility dealing with HBM, part of the AI chips that are powering companies like Nvidia and TSMC to new heights.

Fortune

Hudbay Minerals Inc.: A Mining Stock to Consider Amidst Commodity Demand?

Hudbay Minerals (HBM) easily beat the analysts’ expectations on the top and bottom lines in the third quarter of 2024. Solid market demand for minerals, strategic alliances, favorable regulatory outcomes, and robust financial performance are key drivers of the company’s continued growth. So, let’s determine whether Hudbay Minerals is an…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Materials Stocks to Watch as Demand Rebounds

As industries evolve and economies expand, materials like gold, copper, and steel are key to driving progress. From infrastructure to innovative technologies, the materials industry is vital for global development. Thus, investors looking to capitalize on this growth could explore stable stocks Freeport-McMoRan (FCX), Nucor (NUE), and Hudbay Minerals (HBM).…

StockNews.com

China's CXMT begins mass-producing HBM2 memory well ahead of schedule — 2026 was the previously telegraphed target

China-based memory maker CXMT begins to mass produce HBM2 memory, well ahead of telegraphed mass production in 2026.

Tom’s Hardware

Nvidia’s Jensen Huang plays down competition worries as key supplier disappoints with subdued expectations for AI chip sales

Hype for AI is so feverish that even meeting expectations isn’t enough for investors.

Fortune

1 'Strong Buy' Copper Stock Under $20 to Grab Now

With the demand for copper skyrocketing, investors might consider this copper mining stock under $20, rated “Strong Buy” by analysts.

Barchart

Read news from The Economist, FT, and more,
with one subscription

SK Hynix and TSMC Team Up for HBM4 Development

SK hynix and TSMC announced early on Friday that they had signed a memorandum of understanding to collaborate on developing the next-generation HBM4 memory and advanced packaging technology. The initiative is designed to speed up the adoption of HBM4 memory and solidify SK hynix's and TSMC's leading positions in high-bandwidth…

AnandTech

HBM Revenue Poised To Cross $10B as SK hynix Predicts First Double-Digit Revenue Share

Offering some rare insight into the scale of HBM memory sales – and on its growth in the face of unprecedented demand from AI accelerator vendors – the company recently disclosed that it expects HBM sales to make up "a double-digit percentage of its DRAM chip sales" this year. Which…

AnandTech

Memory maker SK hynix booms during AI frenzy — now controls 35% of the DRAM market

DRAM sales, especially for HBM, have surged on the back of the AI business frenzy, and it's been to SK Hynix's benefit.

Tom’s Hardware

RBC Capital Cuts Hudbay Minerals Price Target By 14%

RBC Capital analyst Sam Crittenden lowered the price target for HudBay Minerals Inc (TSX:HBM) (NYSE:HBM) to C$12 from C$14. The analyst maintained the Outperform rating on the shares. Crittenden stated that, despite what should be the year's weakest quarter, he continues to expect strong FCF and production growth from Hudbay in 2022. The analyst believes…

Benzinga

Preview: Hudbay Minerals's Earnings

Hudbay Minerals (NYSE:HBM) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Hudbay Minerals will report an earnings per share (EPS) of $0.12.

Benzinga

Earnings Outlook For Hudbay Minerals

Benzinga

AstraZeneca Bets $25M On Preclinical Bispecific Antibody

Harbour BioMed has announced a global out-license agreement with AstraZeneca plc (NASDAQ:AZN) for CLDN18.2xCD3 bispecific antibody (HBM7022). HBM7022 is a novel bispecific antibody generated from HBM's HCAb Based Immune Cell Engagers (HBICE) Platform. HBM7022 is currently in the preclinical stage, which crosslinks tumor cells and T cells by targeting a tumor-associated antigen (Claudin18.2) and…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Why Clean Energy Demand Will Keep Copper Prices High

Copper prices are currently hovering near all-time highs due to fears of supply disruptions and low stockpiles. As the world transitions towards clean energy, the demand for copper, a widely used metal in energy generation, is expected to keep surging, leading to a further increase in its prices. Fundamentally strong…

Benzinga

Hudbay Minerals: Q4 Earnings Insights

Hudbay Minerals (NYSE:HBM) reported its Q4 earnings results on Wednesday, February 23, 2022 at 06:00 PM. Here's what investors need to know about the announcement.

Benzinga

Earnings Outlook For Hudbay Minerals

Hudbay Minerals (NYSE:HBM) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts estimate that Hudbay Minerals will report an earnings per share (EPS) of $0.13.

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.